Over the past decade, laser capture microdissection (LCM) has grown as a tool for gene expression profiling of small numbers of cells from tumor samples and of specific cell populations in complex tissues. LCM can be used to study toxicant effects on selected cell populations within the testis at different stages of spermatogenesis. There are several LCM-related hurdles to overcome, including issues inherent to the method itself, as well as biases that result from amplifying the LCM-isolated RNA. Many technical issues associated with the LCM method are addressed here, including increasing RNA yield and obtaining more accurate quantification of RNA yields. We optimized the LCM method optimized to generate RNA quantities sufficient for quantitative reverse transcription polymerase chain reaction (qRT-PCR) array analysis without amplification and were able to validate the method through direct comparison of results from unamplified and amplified RNA from individual samples. The addition of an amplification step for gene expression studies using LCM RNA resulted in a bias, especially for low abundance transcripts. Although the amplification bias was consistent across samples, researchers should use caution when comparing results generated from amplified and unamplified LCM RNA. Here, we have validated the use of LCM-derived RNA with the qRT-PCR array, improving our ability to investigate cell-type and stage-specific responses to toxicant exposures.
INTRODUCTION
Laser capture microdissection (LCM) is a useful technique for isolating populations of cells and subsequently their DNA, RNA, and protein (Cheng et al. 2013; Emmert-Buck et al. 1996) . It is used in molecular profiling of diseases, isolation of small populations of cells from large tissues (i.e., Kupffer cells from the liver [Gehring et al. 2009]) , and examination of cell type-specific toxicant responses Sluka et al. 2008) . Characteristically, LCM is used to capture small numbers of cells for RNA isolation and subsequent amplification in transcriptomic analyses (Subkhankulova and Livesey 2006) . The amplification of LCM material is generally a necessity due to the extensive amount of time required to perform LCM to obtain nanogram amounts of RNA for each sample. Optimization of the LCM method has been the focus of many efforts and has included factors such as the proper selection of consumables and staining reagents, tissue handling, and extraction methods, all to maximize both the quantity and quality of isolated RNA from LCM sections (Sluka et al. 2008 ). Optimization efforts have extended to the examination of various amplification methods and gene expression platforms, and the different biases these may introduce.
LCM isolation of cell populations is a highly manipulated process that generates additional questions, including whether amplification bias occurs and where bias originates (Caretti et al. 2008; Duftner et al. 2008; Lang et al. 2009; Mazurek et al. 2013; Nygaard et al. 2003) . Researchers have compared the use of pooled LCM RNA with different array platforms (Affymetrix U133 plus 2.0 vs. X3P arrays) and different amplification methods (NuGen vs. Arcturus) and have found minimal differences between the methods (Caretti et al. 2008) . Also, unamplified and amplified RNA have been compared using several amplification techniques and varying subnanogram input concentrations of intact total RNA, and found that arrays with unamplified RNA had higher Pearson's correlations than amplified RNA in an unprocessed data set (Lang et al. 2009 ). Utilizing RNA amplification techniques with downstream gene analysis is useful for highly expressed genes but decreases the absolute discovery rate (Lang et al. 2009 ). Furthermore, amplification techniques introduce biases into downstream applications and reduce the signal-to-noise ratio The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the National Institute of Environmental Health Sciences at the National Institutes of Health (grant numbers P42 ES013660 and 5 T32 Toxicologic Pathology, 42: 1221 -1228 , 2014 Copyright # 2014 by The Author(s) ISSN: 0192-6233 print / 1533-1601 online DOI: 10.1177/0192623314526319 (Lang et al. 2009 ), making it difficult to discern subtle changes in gene expression responses. Mazurek et al. (2013) identified an amplification-dependent bias, where the method used resulted in a large number of probe sets with significant expression differences between LCM-derived and whole tissue samples. Here, we validated the use of quantitative reverse transcription polymerase chain reaction (qRT-PCR) arrays with LCM-derived material and examined the effect of amplification on LCM-derived RNA. The comparison of unamplified and amplified versions of the same LCM-derived sample allowed for the direct examination of amplification influence on qRT-PCR array data from LCM-derived RNA.
The testis is a complex organ, with multiple cell types (Sertoli, Leydig, and germ cells) and many varying stages of spermatogenesis depending on the organism. This complexity is compounded when the testicular toxic effects of chemical mixtures are studied. The use of the model germ and Sertoli cell-specific toxicants, X-irradiation (x-ray), and 2,5hexanedione (HD), respectively, can be useful in the investigation of coexposure effects on spermatogenesis because their effects have been well characterized. In previous high-dose studies, the germ cell apoptosis induced by x-ray exposure appears to be attenuated when there is a priming exposure to HD (Campion, Houseman, et al. 2010; Yamasaki, Sandrof, and Boekelheide 2010) . Certain stages of spermatogenesis are more susceptible to particular toxicants, as illustrated by Hasegawa et al. (1997) , who found that a greater number of spermatogonia undergo apoptosis following x-ray exposure during stages I to VI of spermatogenesis, when compared to other stages. This stage-specific effect of toxicant exposure on a few genes involved in the apoptosis of germ cells was studied further through LCM by . They found that when the diluting effect of nonaffected cell types was removed, the apoptotic effects of the toxicants on germ cells was much greater than had previously been realized. The dilution of gene expression effects in whole tissues versus LCM-derived cells becomes more apparent when the subtle effects of low-dose exposures are studied. LCM is required to overcome these complexities associated with the use of multicellular tissues and multiple exposure scenarios in broad gene expression studies.
Here, LCM was applied to study cell types that are targeted by specific toxicants to overcome the attenuation effect that occurs when studying a small subset of cells within a complex multicellular organ (Leblond and Clermont 1952; Moffit et al. 2007) . LCM material was used in conjunction with a qRT-PCR array platform to enhance our ability to detect small gene changes in low-dose exposures across an entire pathway, which would otherwise be lost within the inherent noise of whole genome array studies. Here, we address many of the LCMassociated technical hurdles to ultimately increase RNA yield and maximize the utility of LCM. This optimized and streamlined LCM method generated RNA quantities sufficient for qRT-PCR array analysis without amplification so that we could directly compare results from the use of both unamplified and amplified RNA. The effect of amplification on LCM RNA was examined within samples and across multiple genes to identify potential biases caused by RNA input concentrations used in the amplification process. It was found that there are highly variable amplification rates across several different transcripts on the qRT-PCR array used, but the within-gene amplification was consistent across samples. These data indicate that if comparisons are to be made between unamplified and amplified material, they should be made with caution.
MATERIALS AND METHODS

Animals
Adult male Fischer 344 rats (200-250 g) were purchased from Charles River Laboratories (Wilmington, MA). Upon arrival, rats were acclimated for 1 week and maintained in a temperature and humidity controlled environment with a 12-hr alternating dark-light cycle. All rats were housed in community cages with free access to water and Purina Rodent Chow 5001 (Farmer's Exchange, Framingham, MA). The Brown University Institutional Animal Care and Use Committee approved all experimental animal protocols in compliance with National Institute of Health guidelines.
Toxicant Exposure Animals were exposed using an established treatment protocol (Markelewicz, Hall, and Boekelheide 2004; Yamasaki, Sandrof, and Boekelheide 2010) to 2,5-HD in the drinking water for 18 days as a 0.33% solution. Animals were subsequently exposed to 2 Gy caudal half-body radiation on the 17th day of HD exposure, at a dose rate of 0.31 Gy/min using an RT 250 Philips kVp x-ray machine (Philips, Hamburg, and Germany). At 3 hr following irradiation, the rats were euthanized by CO 2 asphyxiation, and testes were collected and immediately embedded in optimal cutting temperature (OCT) compound (Sakura Finetek, Torrance, CA) as described previously . Only the testis tissue from 4 animals (2 control and 2 HD þ x-ray) of a larger study were chosen randomly for this study, due to the length of time that was required to generate enough LCM RNA without an amplification step.
LCM and RNA Isolation
The LCM method detailed subsequently was optimized for several factors, resulting in a method that could generate enough RNA for use with qRT-PCR arrays without the use of an amplification step. The staining procedure was optimized to obtain better histology, since a cover slip cannot be used with the LCM method. These staining optimizations included the use of a dilute stain solution and a reduction in the amount of time the slides were dehydrated with xylene. In addition, we tested several RNA extraction methods to determine which yielded the greatest amount of high-quality RNA. The addition of multiple LCM cap films to the RNA extraction buffer removed multiple RNA extractions steps, which saved on overall time required and further increased RNA yield. The number of slides to capture for 1222 CATLIN ET AL. TOXICOLOGIC PATHOLOGY each biological replicate was increased to obtain approximately 350 ng of LCM-derived RNA, enough for qRT-PCR array analysis. These optimizations were streamlined into the following detailed method, which takes less time compared to traditional LCM methods to generate the same amount of RNA. Frozen embedded testis tissue was sectioned at 10 mm and bonded to the slide by allowing it to briefly melt and then quickly refreeze. Slides were kept on dry ice until fixation in 75% ethanol for 30 sec. Slides were stained, in groups of 4, for 30 sec in a 0.075% staining solution of Arcturus Histogene Staining Solution (Applied Biosystems, Carlsbad, CA, USA). After a 30 sec wash step with nuclease-free water, slides were moved quickly through the following dehydration steps: 75% ethanol for 30 sec, 95% ethanol for 30 sec, 2Â 100% ethanol for 1 min, and xylene for 1 min. The slides were air dried for 5 min in a hood before use.
The PixCell IIe Laser Microdissection System (Arcturus Bioscience, Inc.) was used to perform LCM according to the manufacturer's manual. The seminiferous tubules with spermatogenesis stages I to VI were identified and the seminiferous tubule peripheral cell layers, which mainly included Sertoli cells, spermatogonia, and spermatocytes, were captured as previously described ; Figure 1A -C). These stages were chosen due to the higher percentage of x-ray sensitive spermatogonia and because of previous research, which has shown that these stages have a higher incidence of apoptosis than other spermatogenesis stages . The cap was removed from the slide and the polymer film was carefully peeled off from the edge with a pair of forceps and placed on ice in 600-ml lysis/binding buffer included in the Ambion mirVana kit (Life Technologies, Grand Island, NY). This process was repeated until all 12 slides of the biological replicate had been completed and the polymer films from each cap of the 12 individual slides were added to the lysis/binding buffer. RNA was isolated from the lysis/binding buffer containing the 12 cap films for each biological replicate using the manufacturer's protocol (2011 version) for the mirVana kit, from step D.2 to step F.I.5 (where indicated, for tissue) and RNA was eluted with nuclease-free water. The above process was repeated 7 times for the same biological replicate to increase RNA yield following the combination and concentration of these replicates, as detailed in the next section.
RNA concentration was determined in triplicate for each of the 7 biological replicates using the low-range protocol detailed by Invitrogen's Quant-iT Ribogreen Assay kit (Life Technologies, Grand Island, NY) and exhibited an improvement in quality, as assessed by RNA integrity number (RIN) from 2100 Bioanalyzer (Agilent, Santa Clara, CA; Figure 2A -C). To conserve the amount of RNA for each sample, RNA quality was assessed for 2 randomly selected sample replicates before RNA concentration, using the 2100 Bioanalyzer (Agilent, Santa Clara, CA), according to the manufacturer's instructions (2010 version).
DNase Treatment and RNA Concentration
The 7 LCM RNA biological replicates were individually DNase treated according to manufacturer's instructions (Qiagen, Valencia, CA), then combined and concentrated during RNA cleanup according to the protocol detailed by Qiagen's RNeasy MinElute Kit, with a few exceptions; after the addition of buffer RLT and 100% ethanol to each of the 7 biological replicates, they were added to the column sequentially. RNA was eluted from the column with 14 ml of nuclease-free water. RNA concentration was determined for each sample in duplicate using the high-range protocol detailed by Invitrogen's Quant-iT Ribogreen Assay kit (Life Technologies, Grand Island, NY). FIGURE 1.-Micrograph of an intact rat seminiferous tubule before laser capture microdissection (LCM; A), the remaining tissue following LCM (B), and the isolated tissue on the LCM cap (C). Scale bar is 50 mm. Vol. 42, No. 8, 2014 LCM METHOD VALIDATION FOR TESTIS ISOLATIONS
qRT-PCR Arrays and Analysis
To assess the utility of LCM-derived RNA, we measured the response of genes across a qRT-PCR array platform, using the RT 2 Profiler PCR Array System (SABiosciences, Valencia, CA) for apoptosis pathway-related genes identified in the rat. Complementary DNA (cDNA) was synthesized from 240 ng of LCM cell-specific RNA using the RT 2 First Strand kit (Qiagen) according to the manufacturer's protocol. To perform a PCR-based preamplification of the genes that are present on the qRT-PCR array, the RT 2 PreAmp cDNA Synthesis Primer Mix (Qiagen) was utilized with 14 ng of input RNA according to the manufacturer's protocol (2012 version). Each sample was run in 10 ml reactions, which were loaded onto the qRT-PCR array (a 4 Â 96-well array was used) with an epMotion 5075 robot (Eppendorf, Hamburg, Germany). An ABI-7900HT PCR machine (Applied Biosystems, Grand Island, NY) was used with the following cycling program: 95 C for 10 min, 40 cycles of 95 C for 15 sec, and 60 C for 1 min, followed by a dissociation step. We selected the 3 optimal housekeeping genes for the 2 data sets (amplified and unamplified) from the 5 measured (Actb, B2m, Hprt1, Ldha, and Rplp1) and normalized the mRNA expression levels DCycle threshold (DCt) using the R package SLqPCR which implements Vandesompele et al. (2002) .
The LCM-derived RNA (n ¼ 2, 0.33% HD) samples with the highest concentrations were also sent to the service core of SABiosciences to compare the reproducibility of our results. Within the pre-amplification step, they used 100 ng of input RNA. These amplified samples were loaded onto the apoptosis PCR array, along with their unamplified versions, and the same PCR cycling program was used. SABiosciences normalized the data using the arithmetic mean of all 5 housekeeping genes in the data they provided.
RNA Amplification Comparison and Statistical Analysis
The ratios, correlations, means, and standard deviations (SD) were calculated using the R Statistical environment and plotted in both R and Prism (Graphpad Software, Inc., La Jolla, CA). The data from both unamplified and amplified LCM-derived RNA were plotted against each other for examination of the effect of amplification on the data. The Ct values for differing input concentrations of RNA for amplification were plotted, and the r 2 and p values determined using a linear regression in Prism Graphpad.
RESULTS
The process of LCM, from microdissection to concentration of RNA replicates from 1 sample, is outlined in Figure 3 . This process was repeated 7 times to compensate for RNA loss during DNase treatment and concentration to ensure that sufficient RNA could be isolated despite eliminating an amplification step. The process yielded approximately 350 ng of RNA. Seminiferous tubules were chosen for microdissection based on their stage of spermatogenesis (stages I-VI). The peripheral cell layers of the seminiferous tubules were captured, which mainly included Sertoli cells, spermatogonia, spermatocytes, and spermatids ( Figure 1C ). An improvement in integrity was seen following RNA combination and concentration, as assessed by RIN from 2100 Bioanalyzer (Figure 2A-C) . The before and after DNase treatment and RNA concentration steps yielded RINs of 5.40 and 6.50, respectively (Agilent, Santa Clara, CA).
To examine the variability of the ratio of amplified to unamplified Ct values, we compared the ratios of 4 samples, 2 controls, and 2 exposed (Figure 4) . The mean amplification ratio for the combined four samples ranged from about 1 to 2, indicating different amplification rates for each gene. However, the error bars (1 SD) show that the amplification ratio of the genes is very consistent between the 4 samples, implying consistency of amplification on a gene-by-gene basis.
To explore the potential for amplification bias, the DCt values generated for the amplified LCM-derived samples were compared to their unamplified counterparts ( Figures  5 and 6 ). LCM-derived samples (n ¼ 2, 0.33% HD) were also sent to SABiosciences for an unamplified versus amplified samples to verify our methods and to compare the reproducibility of the results. The comparison of biological replicates (controls) between amplified and unamplified DCt values for each gene present on the array show strong correlations with r 2 values of 0.99 and 0.98, respectively (Figure 5A and B) . The data for the 0.33% þ 2 Gy biological replicates are not shown, but demonstrate the same strong correlations. Likewise, the comparison of the DCt values between the amplified and unamplified biological replicates performed by SABiosciences yields the same strong correlations, with r 2 values of 0.98 and 0.97, respectively ( Figure  5C and D) .
The 9 data points highlighted in red in Figure 5A -D are outliers in the comparison of the DCt values for unamplified versus amplified material generated by our lab. The unamplified and amplified DCt values generated by our lab correlate with an r 2 of 0.94, with the exception of these 9 outliers: Mapk1, Mapk8ip1, Birc3, Birc5, Il10, Polb, Fadd, Casp1, and Tp53bp2. Interestingly, these outliers correlate with each other just as well (r 2 ¼ 0.94; Figure 6A ). The SABiosciences data also correlate well (r 2 ¼ 0.92), but the outliers from Figure  6A are no longer outliers with their data, with the exception of 1 data point ( Figure 6B) .
The amount of input RNA that goes into an amplification reaction may affect the quality of results obtained. Different amounts of pooled LCM RNA (7, 14, 35, and 98 ng) were used as input into the pre-amplification step to test the role of input concentration in PCR array results (Figure 7) . In Figure 7A , the correlation between 14 ng of input RNA and 7 ng, 35 ng, and 98 ng was strong, with r 2 values of 0.98, 0.98, and 0.95, respectively. The Ct values were compared among each gene at each input RNA amount ( Figure 7B ). As expected, increasing the input concentration lowers the number of cycles required to reach the threshold at a rate consistent within transcripts but not Ratio of mean (and standard deviation) of amplified to unamplified mean cycle ratios across genes using sample data from both our lab and SABiosciences. Genes highlighted in black, Traf3, Tp53, Faslg, Dffb, Bcl2a1d, and Bcl2l11, have a high standard deviation. FIGURE 3.-Laser capture microdissection (LCM) method schematic. For 1 sample replicate, about 20 seminiferous tubules from 12 slides were microdissected. The polymer film from each cap was peeled off and placed into 600 ml of mirVana Lysis/Binding buffer until all slides had been microdissected. After the final film had been added, the film/buffer mixture was incubated on ice for 45 min, following which, RNA was extracted using the mirVana kit. This process was repeated 7 times and then each replicate was DNase treated, then combined and concentrated using the RNeasy MinElute kit, yielding approximately 350 ng of RNA. Vol. 42, No. 8, 2014 LCM METHOD VALIDATION FOR TESTIS ISOLATIONS 1225 between transcripts. The genes that demonstrated the largest variance in Ct values are labeled in black and these include Tnfrsf11b, Birc5, Bnip2, Dffa, Bak1, and Bcl10.
DISCUSSION
LCM has proved to be a useful technique for isolating not only toxicant sensitive cell types, but also in isolating spermatogenesis stage-specific cell populations (Sluka, O'Donnell, and Stanton 2002) . Cells are selected based on their morphology and used in downstream applications such as qRT-PCR and gene microarrays. Although this technique allows for cell-specific analysis, there are associated hurdles that need to be overcome to maximize the utility of LCM. Some of these issues, such as tissue handling, consumables, staining reagents and extraction methods, have already been addressed by previous methodology articles (Sluka et al. 2008) .
In the optimization of LCM as a tool for studying stagespecific effects of testicular toxicants, additional issues needed FIGURE 6.-Consistency of RNA input method within samples. The unamplified and amplified DCt values were compared within samples for a control sample from our lab (A) and a 0.33% HD exposed sample from SABiosciences (B). The data points highlighted in red (A) indicate outliers in the correlation and the corresponding genes for the data points are labeled. to be addressed. Our streamlined method ( Figure 3 ) addressed hurdles such as the limited concentrations of RNA generated by traditional LCM methods and the accuracy of quantification methods. With repeated capture of multiple slides from the same biological replicate combined with pooling of several of these replicates, we achieved both increased RNA yields (approximately 350 ng) and improved quality following concentration per biological sample (Figures 3 and 1) . The method detailed here can be used to avoid an amplification step, while still reliably generating enough quality RNA to be used in downstream studies such as qRT-PCR arrays and microarrays. The amplification ratio ranges from 1 to 2 across the transcripts, but the SD of the ratios are small (Figure 4) . These results indicate that there are highly variable amplification rates across the different transcripts, but the within-transcript amplification is consistent across samples. This argues that comparisons between transcripts should not be made without a correction factor adjusting for the amplification ratio, while the results from single transcripts on the PCR array across multiple samples are comparable. The transcripts with highly variable mean cycle amplification ratios (Tp73, Tnfsf12, Tnfsf10, Dffa, Bak1, and Bcl10; Figure 4 ) are either present at low levels within the testis and/or not in the spermatogenesis stages or cell types captured (Grataroli et al. 2002; Hamer et al. 2001; Song et al. 2008) , which would explain some of the variability observed.
To examine the potential for amplification bias, we used the method outlined in Figure 3 to generate enough RNA to compare unamplified and amplified versions of the same sample on a PCR array platform. The same samples were analyzed in 2 different laboratories, providing independent replication of the experiment. From either lab, both the unamplified and the amplified DCt values showed a strong, within-method correlation of log-fold expression ( Figure 5 ). There was also a strong correlation in the comparison of unamplified to amplified DCt values from both labs, but the labs differed in the presence or absence of outliers ( Figure 6 ). This discrepancy was attributed to the amount of input RNA used for pre-amplification (14 ng vs. 100 ng of input RNA). Amplified samples resulting from a higher amount of input RNA were more consistent across the range of transcript abundance in the sample ( Figure 5 ). Some of the outlying genes, though expressed in the testis, were not highly expressed within the cell types that were microdissected ( Figure 6 ). For example, the Mapk1 and Mapk8ip1 transcripts are more abundant within Leydig cells (Thompson et al. 2001; Yamashita et al. 2011) , and Il10 is produced by resident testicular macrophages upon inflammation (Winnall, Muir, and Hedger 2011) . These data demonstrate the need for caution when comparing LCM-derived unamplified to pre-amplified results, in particular with transcripts that are known to be of low abundance, and thus may not amplify at the same rate.
To better understand the amplification bias, we examined the effect of low RNA concentration on PCR threshold cycles by varying the input RNA amounts to be amplified. The RNA amounts were chosen based on the RNA concentration that is typically achieved with the LCM method. The respective threshold cycle values for each RNA input amount were compared across the different genes on the PCR array ( Figure 7B ). The amplification Ct values for 7 ng, 35 ng, and 98 ng of RNA input were compared to the Ct values from 14 ng of RNA input and show strong correlations across all the input values tested ( Figure 7A ). There was more variance with low concentration transcripts (Ct > 25), when the amplification input RNA was either very low (7 ng) or very high (98 ng). Here, the choice of input RNA amount makes little difference; however, when comparing the expression of low abundance transcripts in combination with low input RNA, the Ct values may fall below detection.
The use of LCM is often necessary to obtain insight into small subsets of cells within a larger population, whether these are toxicant-sensitive cells in a multicellular tissue or specific cancerous cells within a tissue. Here, we present an improved and reliable LCM method for generating greater amounts of RNA for downstream analyses and validate the use of a qRT-PCR array with the LCM-derived RNA. In a companion study, the validated method presented here was applied to the study of coexposure effects on gene expression in specific cell types targeted by varying low doses of the toxicants HD and xray (Catlin et al. 2013b) . Apoptosis specific PCR arrays were Vol. 42, No. 8, 2014 LCM METHOD VALIDATION FOR TESTIS ISOLATIONS 1227 utilized to examine the testis cell-specific response, and conclusions were drawn based on the expression data combined with histological data from the literature. Amplification is almost always necessary with LCMderived samples, and it can introduce bias in the consistency of amplification across transcripts. Given the variability in low abundance genes from the amplification of LCM-derived RNA in this study, it is important to take low RNA input amounts into consideration when comparing results between unamplified and amplified input RNA experiments. We have determined the genes that are inconsistently amplified across the apoptosis PCR array platform with rat testis LCM-derived RNA. We recommend that a screening procedure be used with future applications of this method to determine those genes that will not respond to amplification due to low abundance.
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